Compensated right ventricular function of the onset of pulmonary hypertension in a rat model depends on chamber remodeling and contractile augmentation.

Abstract:

:Right-ventricular function is a good indicator of pulmonary arterial hypertension (PAH) prognosis; however, how the right ventricle (RV) adapts to the pressure overload is not well understood. Here, we aimed at characterizing the time course of RV early remodeling and discriminate the contribution of ventricular geometric remodeling and intrinsic changes in myocardial mechanical properties in a monocrotaline (MCT) animal model. In a longitudinal study of PAH, ventricular morphology and function were assessed weekly during the first four weeks after MCT exposure. Using invasive measurements of RV pressure and volume, heart performance was evaluated at end of systole and diastole to quantify contractility (end-systolic elastance) and chamber stiffness (end-diastolic elastance). To distinguish between morphological and intrinsic mechanisms, a computational model of the RV was developed and used to determine the level of prediction when accounting for wall masses and unloaded volume measurements changes. By four weeks, mean pulmonary arterial pressure and elastance rose significantly. RV pressures rose significantly after the second week accompanied by significant RV hypertrophy, but RV stroke volume and cardiac output were maintained. The model analysis suggested that, after two weeks, this compensation was only possible due to a significant increase in the intrinsic inotropy of RV myocardium. We conclude that this MCT-PAH rat is a model of RV compensation during the first month after treatment, where geometric remodeling on EDPVR and increased myocardial contractility on ESPVR are the major mechanisms by which stroke volume is preserved in the setting of elevated pulmonary arterial pressure. The mediators of this compensation might themselves promote longer-term adverse remodeling and decompensation in this animal model.

journal_name

Pulm Circ

journal_title

Pulmonary circulation

authors

Vélez-Rendón D,Zhang X,Gerringer J,Valdez-Jasso D

doi

10.1177/2045894018800439

subject

Has Abstract

pub_date

2018-10-01 00:00:00

pages

2045894018800439

issue

4

eissn

2045-8932

issn

2045-8940

journal_volume

8

pub_type

杂志文章
  • Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension.

    abstract::Atrial arrhythmias are common during episodes of acute respiratory failure in patients with chronic lung disease-associated pulmonary hypertension. Expert opinion suggests that management of atrial arrhythmias in patients with pulmonary hypertension should aim to restore sinus rhythm. This is clinically challenging in...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1177/2045894020910685

    authors: Vahdatpour CA,Luebbert JJ,Palevsky HI

    更新日期:2020-03-09 00:00:00

  • Levosimendan in pulmonary hypertension and right heart failure.

    abstract::Pulmonary hypertension is a multifactorial disease with a high morbidity and mortality. Right ventricular function is the most important predictor of morbidity and mortality in patients suffering from pulmonary hypertension, but currently there are no approved treatments directly supporting the failing right ventricle...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018790905

    authors: Hansen MS,Andersen A,Nielsen-Kudsk JE

    更新日期:2018-07-01 00:00:00

  • Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxia.

    abstract::Obesity is causally linked to a number of comorbidities, including cardiovascular disease, diabetes, renal dysfunction, and cancer. Obesity has also been linked to pulmonary disorders, including pulmonary arterial hypertension (PAH). It was long believed that obesity-related PAH was the result of hypoventilation and h...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/678510

    authors: Irwin DC,Garat CV,Crossno JT Jr,MacLean PS,Sullivan TM,Erickson PF,Jackman MR,Harral JW,Reusch JE,Klemm DJ

    更新日期:2014-12-01 00:00:00

  • Rescue balloon pulmonary angioplasty in a rapidly deteriorating chronic thromboembolic pulmonary hypertension patient with liver failure and refractory infection.

    abstract::Pulmonary endarterectomy (PEA) is the standard therapy for chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) is an alternative therapy for such patients. Here we report the case of a 60-year-old woman who presented with severe CTEPH resulting in low cardiac output and liver fai...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1086/675643

    authors: Tsuji A,Ogo T,Demachi J,Ono Y,Sanda Y,Morita Y,Fukuda T,Nakanishi N

    更新日期:2014-03-01 00:00:00

  • Low-grade albuminuria in pulmonary arterial hypertension.

    abstract::Low-grade albuminuria, determined by the urinary albumin to creatinine ratio, has been linked to systemic vascular dysfunction and is associated with cardiovascular mortality. Pulmonary arterial hypertension is related to mutations in the bone morphogenetic protein receptor type 2, pulmonary vascular dysfunction and i...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018824564

    authors: Nickel NP,de Jesus Perez VA,Zamanian RT,Fessel JP,Cogan JD,Hamid R,West JD,de Caestecker MP,Yang H,Austin ED

    更新日期:2019-04-01 00:00:00

  • Addition of a bilateral access form of peripheral extracorporeal membrane oxygenation rescued a patient with idiopathic pulmonary arterial hypertension who developed circulatory collapse immediately after childbirth.

    abstract::Pregnancy is not advised for patients with Pulmonary hypertension (PH) because of high risk of PH crisis. However, some patients have undiagnosed idiopathic pulmonary arterial hypertension (IPAH) before pregnancy. Upfront combination therapy has high efficacy for patients with IPAH. However, some patients are unable t...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045894020910140

    authors: Adachi S,Shimokata S,Yoshida M,Imai R,Nakano Y,Okumura N,Suzuki S,Murohara T,Kondo T

    更新日期:2020-02-28 00:00:00

  • Pulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA.

    abstract::Pulmonary arterial hypertension (PAH) is characterized by obstruction of pre-capillary pulmonary arteries, which leads to sustained elevation of pulmonary arterial pressure. Identifying those at risk through early interventions, such as genetic testing, may mitigate disease course. Current practice guidelines recommen...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217700156

    authors: Jacher JE,Martin LJ,Chung WK,Loyd JE,Nichols WC

    更新日期:2017-04-01 00:00:00

  • Idiopathic hypereosinophilic syndrome with pulmonary hypertension.

    abstract::Hypereosinophilic syndrome is a myeloproliferative disorder characterized by persistent eosinophilia with involvement of multiple organs. The occurrence of severe pulmonary hypertension (PH) in the setting of hypereosinophilic syndrome is very uncommon. A 43-year-old man with documented idiopathic hypereosinophlic syn...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045894018793999

    authors: Zhang L,Peng X,Adhikari BK,Li B,Liu Q,Mikeladze J,Zhang W

    更新日期:2019-01-01 00:00:00

  • The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study.

    abstract::Patients with chronic thromboembolic pulmonary hypertension (CTEPH) require lifelong anticoagulation therapy. However, the bleeding risk and recurrence of venous thromboembolism (VTE) in CTEPH patients who are administered warfarin have not been adequately evaluated. The purpose of this study was to evaluate the risk ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217717258

    authors: Jujo-Sanada T,Tanabe N,Sakao S,Sugiura T,Sekine A,Nishimura R,Suda R,Naito A,Miwa H,Yamamoto K,Sasaki A,Matsumura A,Ema R,Kasai H,Kato F,Tatsumi K

    更新日期:2017-07-01 00:00:00

  • Particulate matter disrupts human lung endothelial cell barrier integrity via Rho-dependent pathways.

    abstract::Increased exposure to ambient particulate matter (PM) is associated with elevated morbidity and mortality in patients with cardiopulmonary diseases and cancer. We and others have shown that PM induces lung microvascular barrier dysfunction which potentially enhances the systemic toxicity of PM. However, the mechanisms...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/689906

    authors: Wang T,Shimizu Y,Wu X,Kelly GT,Xu X,Wang L,Qian Z,Chen Y,Garcia JGN

    更新日期:2017-07-01 00:00:00

  • Erratum.

    abstract::[This corrects the article DOI: 10.1086/688060.]. ...

    journal_title:Pulmonary circulation

    pub_type: 已发布勘误

    doi:10.1086/689215

    authors:

    更新日期:2016-12-01 00:00:00

  • Characterization of altered patterns of endothelial progenitor cells in sickle cell disease related pulmonary arterial hypertension.

    abstract::Endothelial dysfunction plays an important role in the pathogenesis of pulmonary arterial hypertension (PAH) in sickle cell disease (SCD). A variety of evidence suggests that circulating endothelial progenitor cells (EPCs) play an integral role in vascular repair. We hypothesized that SCD patients with PAH are deficie...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.94834

    authors: Anjum F,Lazar J,Zein J,Jamaleddine G,Demetis S,Wadgaonkar R

    更新日期:2012-01-01 00:00:00

  • The genetics of pulmonary arterial hypertension in the post-BMPR2 era.

    abstract::Pulmonary arterial hypertension (PAH) is a rapidly progressive and fatal disease for which there is an ever-expanding body of genetic and related pathophysiological information on disease pathogenesis. The most common single culprit gene known is BMPR2, and animal models of the disease in several forms exist. There is...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.87293

    authors: Fessel JP,Loyd JE,Austin ED

    更新日期:2011-07-01 00:00:00

  • MicroRNA expression profile of pulmonary artery smooth muscle cells and the effect of let-7d in chronic thromboembolic pulmonary hypertension.

    abstract::Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is a life-threatening condition characterized by single or recurrent pulmonary thromboemboli, which promote pulmonary vascular remodeling. MicroRNA (miRNA), is a small, noncoding RNA that is involved in multiple cell processes and functions and may partici...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/674310

    authors: Wang L,Guo LJ,Liu J,Wang W,Yuan JX,Zhao L,Wang J,Wang C

    更新日期:2013-09-01 00:00:00

  • Effects of exercise rehabilitation training on patients with pulmonary hypertension.

    abstract::Pulmonary hypertension (PH) comprises a group of pathophysiological syndromes characterized by elevated pulmonary artery pressure and pulmonary vascular resistance, which lead to right ventricular overload, and even right heart failure. PH has a poor prognosis and severely leads to a decline in quality of life. Histor...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1177/2045894020937129

    authors: Zhang X,Xu D

    更新日期:2020-07-07 00:00:00

  • Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing.

    abstract::Pulmonary capillary hemangiomatosis (PCH) is a rare form of pulmonary arterial hypertension (PAH) characterized by pulmonary capillary proliferation and pseudoinvasion of collagenous septal structures. PCH is often accompanied by veno-occlusive changes and pulmonary hypertensive arterial remodeling. The clinical and p...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1086/682227

    authors: DuBrock HM,Kradin RL,Rodriguez-Lopez JM,Channick RN

    更新日期:2015-09-01 00:00:00

  • Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease.

    abstract::Rapid access to lung-derived cells from stable subjects is a major challenge in the pulmonary hypertension field, given the relative contraindication of lung biopsy. In these studies, we sought to demonstrate the importance of evaluating a cell type that actively participates in disease processes, as well as the poten...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/688314

    authors: Gaskill C,Marriott S,Pratap S,Menon S,Hedges LK,Fessel JP,Kropski JA,Ames D,Wheeler L,Loyd JE,Hemnes AR,Roop DR,Klemm DJ,Austin ED,Majka SM

    更新日期:2016-12-01 00:00:00

  • Late-onset pulmonary arterial hypertension in repaired D-transposition of great arteries: an uncommon complication.

    abstract::Late-onset pulmonary arterial hypertension (PAH) is a rare but fatal complication in patients with childhood surgical repair of dextro-transposition of great arteries (D-TGA), especially with the Mustard and Senning procedures. The pathogenic mechanisms of PAH in patients with repaired D-TGA are not well understood an...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045893217699228

    authors: Baskaran J,March KS,Thenappan T

    更新日期:2017-04-01 00:00:00

  • Change in R wave in lead V1 predicts survival of patients with pulmonary arterial hypertension.

    abstract::Clinical guidelines for pulmonary hypertension recommend evaluating treatment response through various methods; however, electrocardiography (ECG) is not included as one of the methods of choice. We aimed to identify ECG parameters that correlated with prognosis in patients with pulmonary arterial hypertension (PAH). ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018776496

    authors: Sato S,Ogawa A,Matsubara H

    更新日期:2018-04-01 00:00:00

  • Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food.

    abstract::Riociguat is approved for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Some patients have difficulty swallowing tablets; therefore, 2 randomized, nonblinded, crossover studies compared the relative bioavailability of riociguat oral suspensions and immediate-releas...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/685020

    authors: Saleh S,Frey R,Becker C,Unger S,Wensing G,Mück W

    更新日期:2016-03-01 00:00:00

  • Dynamic right ventricular-pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension.

    abstract::Despite recent advances, the prognosis of pulmonary hypertension (PH) remains poor. While the initial insult in PH implicates the pulmonary vasculature, the functional state, exercise capacity, and survival of such patients are closely linked to right ventricular (RV) function. In the current study, we sought to inves...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019862435

    authors: Singh I,Rahaghi FN,Naeije R,Oliveira RKF,Vanderpool RR,Waxman AB,Systrom DM

    更新日期:2019-07-01 00:00:00

  • S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs.

    abstract::This study aimed to identify receptors mediating sphingosine-1-phosphate (S1P)-induced vasoconstriction in the normotensive and chronic hypoxia-induced hypertensive rat pulmonary circulation. In isolated perfused lungs from normoxic rats, infusion of S1P caused a sustained vasoconstriction, which was not reduced by co...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.87309

    authors: Ota H,Beutz MA,Ito M,Abe K,Oka M,McMurtry IF

    更新日期:2011-07-01 00:00:00

  • Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism.

    abstract::Pulmonary embolism is associated with high rates of mortality and morbidity. It is important to understand direct comparisons of current interventions to differentiate favorable outcomes and complications. The objective of this study was to compare ultrasound-accelerated thrombolysis versus systemic thrombolysis versu...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894020953724

    authors: Antoine D,Chuich T,Mylvaganam R,Malaisrie C,Freed B,Cuttica M,Schimmel D Jr

    更新日期:2020-09-28 00:00:00

  • Reactive oxygen species scavengers improve voltage-gated K(+) channel function in pulmonary arteries of newborn pigs with progressive hypoxia-induced pulmonary hypertension.

    abstract::Abstract Changes in voltage-gated K(+) (Kv) channel function contribute to the pathogenesis of pulmonary hypertension. Yet the mechanisms underlying Kv channel impairments in the pulmonary circulation remain unclear. We tested the hypothesis that reactive oxygen species (ROSs) contribute to the Kv channel dysfunction ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/674307

    authors: Fike CD,Aschner JL,Kaplowitz MR,Zhang Y,Madden JA

    更新日期:2013-09-01 00:00:00

  • Nonmuscle myosin light chain kinase activity modulates radiation-induced lung injury.

    abstract::Radiotherapy as a primary treatment for thoracic malignancies induces deleterious effects, such as acute or subacute radiation-induced lung injury (RILI). Although the molecular etiology of RILI is controversial and likely multifactorial, a potentially important cellular target is the lung endothelial cytoskeleton tha...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/686491

    authors: Wang T,Mathew B,Wu X,Shimizu Y,Rizzo AN,Dudek SM,Weichselbaum RR,Jacobson JR,Hecker L,Garcia JG

    更新日期:2016-06-01 00:00:00

  • Comparative effectiveness of oral prostacyclin pathway drugs on hospitalization in patients with pulmonary hypertension in the United States: a retrospective database analysis.

    abstract::Two oral medications targeting the prostacyclin pathway are available to treat pulmonary arterial hypertension in the United States: oral treprostinil and selexipag. We compared real-world hospitalization in patients receiving these medications. A retrospective administrative claims study was conducted using the Optum...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894020911831

    authors: McConnell JW,Tsang Y,Pruett J,Iii WD

    更新日期:2020-11-10 00:00:00

  • Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients.

    abstract::The biological mechanisms behind the development of pulmonary hypertension in the setting of left heart failure (HF-PH), including combined pre- and post-capillary pulmonary hypertension (Cpc-PH), remains unclear. This study aimed to use candidate polymorphisms in nitric oxide synthase (NOS) genes to explore the role ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018773049

    authors: Duarte JD,Kansal M,Desai AA,Riden K,Arwood MJ,Yacob AA,Stamos TD,Cavallari LH,Zamanian RT,Shah SJ,Machado RF

    更新日期:2018-04-01 00:00:00

  • Adverse physiologic effects of Western diet on right ventricular structure and function: role of lipid accumulation and metabolic therapy.

    abstract::Little is known about the impact of metabolic syndrome (MS) on right ventricular (RV) structure and function. We hypothesized that mice fed a Western diet (WD) would develop RV lipid accumulation and impaired RV function, which would be ameliorated with metformin. Male C57/Bl6 mice were fed a WD or standard rodent die...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018817741

    authors: Brittain EL,Talati M,Fortune N,Agrawal V,Meoli DF,West J,Hemnes AR

    更新日期:2019-01-01 00:00:00

  • Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol.

    abstract::Infection, thrombosis, and catheter dislodgment are well-recognized potential complications of chronic intravenous prostanoid therapy for pulmonary arterial hypertension. As long-term outcomes of pulmonary hypertension patients improve, novel adverse events are likely to arise. We describe the sudden development of un...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045893217748054

    authors: LeVarge BL,Law AC,Murphy B

    更新日期:2018-01-01 00:00:00

  • Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

    abstract::Pulmonary hypertension is recognized as a leading cause of morbidity and mortality in patients with sickle cell disease (SCD). We now report benchtop phenotyping from the explanted lungs of the first successful lung transplant in SCD. Pulmonary artery smooth muscle cells (PASMCs) cultured from the explanted lungs were...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/674754

    authors: Rogers NM,Yao M,Sembrat J,George MP,Knupp H,Ross M,Sharifi-Sanjani M,Milosevic J,St Croix C,Rajkumar R,Frid MG,Hunter KS,Mazzaro L,Novelli EM,Stenmark KR,Gladwin MT,Ahmad F,Champion HC,Isenberg JS

    更新日期:2013-12-01 00:00:00